Please wait. Loading...
 

Δημοσιεύσεις σε Διεθνή Επιστημονικά Περιοδικά

78.   Biologic Treatment Options for Retinal Neovascularization in Behcet Disease.  

Markomichelakis NN, Aissopou EK, Maselos S, Tugal-Tutkun I, Sfikakis PP.                    

Ocul Immunol Inflamm. 2019;27(1):51-57.

77.   Induction of ocular Behcet disease remission after short-term treatment with infliximab: a case series of 11 patients with a follow-up from 4 to 16 years.                        

Sfikakis PP, Arida A, Ladas DS, Markomichelakis N.                                                                              

Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):137-141.

76.   Bilateral acute iris transillumination following systemic administration of antibiotics.

Tranos P, Lokovitis E, Masselos S, Kozeis N, Triantafylla M, Markomichelakis N.         

Eye (Lond). 2018 Jul;32(7):1190-1196.

75.   Brief Report: Drug-Free Long-Term Remission in Severe Behcet Disease Following Withdrawal of Successful Anti-Tumor Necrosis Factor Treatment.                           

Sfikakis PP, Arida A, Panopoulos S, Fragiadaki K, Pentazos G, Laskari K, Tektonidou M, Markomichelakis N.

Arthritis Rheumatol. 2017 Dec;69(12):2380-2385.

74.   The role of fundus autofluorescence imaging in the study of the course of posterior uveitis disorders.

Malamos P, Masaoutis P, Georgalas I, Maselos S, Andrianopoulos K, Koutsandrea C, Markomichelakis NN.

Biomed Res Int. 2015;2015:247469.

73.   Acute zonal occult outer retinopathy with atypical findings.                                              

Karagiannis D, Kontadakis GA, Kandarakis AS, Markomichelakis N, Georgalas I, Parikakis EA, Kabanarou SA.

Case Rep Med. 2014;2014:290696.

72.   Evaluation of single-dose azithromycin versus standard azithromycin/doxycycline treatment and clinical assessment of regression course in patients with adult inclusion conjunctivitis.

Malamos P, Georgalas I, Rallis K, Andrianopoulos K, Georgopoulos G, Theodossiadis P, Vergados I, Markomichelakis NN.

Curr Eye Res. 2013 Dec;38(12):1198-206.

71.   Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization.                                                            

Petrou P, Georgalas I, Markomichelakis N, Vergados I, Gianakaki E, Rouvas A.                            

Ther Clin Risk Manag. 2013;9:391-4.

70.   Evaluation of direct immunofluorescence assay and cytological examination in comparison to polymerase chain reaction of conjunctival swabs in patients with adult inclusion conjunctivitis.

Malamos P, Georgalas I, Rallis K, Andrianopoulos K, Konstantoulakis P, Georgopoulos G, Theodosiadis P, Markomichelakis NN.                                                                                                 

Semin Ophthalmol. 2013 Jul;28(4):216-23.

69.   Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia.                                                         

Rouvas A, Malamos P, Douvali M, Ntouraki A, Markomichelakis NN.                                 

Clin Ophthalmol. 2013;7:1357-62.

68.   Human herpes virus-6 as a cause of recurrent posterior uveitis in a HIV-positive patient.  

Malamos P, Maselos S, Andrianopoulos K, Georgalas I, Chryssos G, Markomichelakis NN.

Retin Cases Brief Rep. 2013 Spring;7(2):131-3.

67.   Association of lysyl oxidase-like 1 gene common sequence variants in Greek patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.            

Metaxaki I, Constantoulakis P, Papadimitropoulos M, Filiou E, Georgopoulos G, Chamchougia A, Papakonstantinou D, Markomichelakis N, Koutsandrea C, Halkiadakis I

Mol Vis. 2013 Jul 12;19:1446-52. Print 2013.

66.   Idiopathic retinal vasculitis, arteriolar macroaneurysms and neuroretinitis: clinical course and treatment.

Rouvas A, Nikita E, Markomichelakis N, Theodossiadis P, Pharmakakis N.                            

J Ophthalmic Inflamm Infect. 2013 Jan 25;3(1):21.

65.   Intravitreal infliximab for sight-threatening relapsing uveitis in Behcet disease: a pilot study in 15 patients.

Markomichelakis N, Delicha E, Masselos S, Sfikakis PP.                                                                           

Am J Ophthalmol. 2012 Sep;154(3):534-541.e1.

64.   Atypical unilateral maculopathy associated with acute exudative polymorphous vitelliform maculopathy-like yellowish deposits.                                                                

Bruè C, Barbazetto I, Markomichelakis NN, Yannuzzi LA, Bailey Freund K, Kotsolis AI.        

Retin Cases Brief Rep. 2012 Spring;6(2):135-8..

63.   Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.

Lowder C, Belfort R Jr, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM; Ozurdex HURON Study Group.                                                                                        

Arch Ophthalmol. 2011 May;129(5):545-53.

62.   Structural and functional outcomes after treatment of uveitic macular oedema: an optical coherence tomography and multifocal electroretinogram study         

Georgiadou E, Moschos MM, Margetis I, Chalkiadakis J, Markomichelakis NN.           

Clin Exp Optom. 2012 95(1):89-93.

61.   Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization          

Rouvas A, Petrou P, Douvali M, Ntouraki A, Vergados I, Georgalas I, Markomichelakis N.

Retina. 2011;31(5):871-9.

60.   Extensive unilateral visual field loss due to peripapillary arteriovenous malformation.

Rouvas A, Petrou P, Ladas I, Vergados I, Andipa ES, Papathanasiou M, Markomichelakis N. 

Int Ophthalmol. 2011 Apr;31(2):135-9.

59.   A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behcet disease: a comparative 4-week study                                                                             

Markomichelakis N, Delicha E, Masselos S, Fragiadaki K, Kaklamanis P, Sfikakis PP.

Rheumatology (Oxford). 2011;50(3):593-7

58.   Intraocular safari: ophthalmomyiasis interna.                                                            

Georgalas I, Ladas I, Maselos S, Lymperopoulos K, Markomichelakis N.                                         

Clin Experiment Ophthalmol. 2011;39(1):84-5

57.   Are clusters of patients with distinct clinical expression present in Behcet disease?

Arida A, Vaiopoulos G, Markomichelakis N, Kaklamanis P, Sfikakis PP.                                            

Clin Exp Rheumatol. 2009;27(2 Suppl 53):S48-51.

56.   Retinal angiomatous proliferation (RAP) in a 42-year-old woman with syphilitic retinitis

Rouvas A, Petrou P, Maselos S, Douvali M, Vergados I, Markomichelakis N.                  

Ocul Immunol Inflamm. 2009;17(5):361-3.

55.   Infectious uveitis in children                                                                                        

Markomichelakis NN, Chatzistefanou KI, Papaefthymiou I, Koutsandrea C, Kouris T, Apostolopoulos M                                                                                                    

Ophthalmology. 2009 ;116(8):1588, 1588.

54.   Efficacy and safety of latanoprost in eyes with uveitic glaucoma               

Markomichelakis NN, Kostakou A, Halkiadakis I, Chalkidou S, Papakonstantinou D, Georgopoulos G.                                                                                                                      

Graefes Arch Clin Exp Ophthalmol. 2009;247(6):775-80.

53.   Retinal detachment due to a macular hole in a patient with Behcet disease treated with vitrectomy and silicone oil tamponade                                                                              

Georgalas I, Markomichelakis N, Ladas I.                                                                                                    

Eur J Ophthalmol. 2008 ;18(6):1023-4.

52.   Tumor necrosis factor inhibitors and uveitis: comment on the article by Lim et al

Sfikakis PP, Markomichelakis N.                                                                                                          

Arthritis Rheum. 2008;58(5):1554-5; author reply

51.   Spinocerebellar ataxia type 7 presenting as Stargardt disease                           

T sivgoulis G, Vassilopoulou S, Rallis K, Markomichelakis N, Spengos K.                          

J Neurol. 2008;255(3):456-8.

50.   Course of macular edema in uveitis under medical treatment.                

Markomichelakis NN, Halkiadakis I, Pantelia E, Georgalas E, Koutsandrea C, Theodossiadis P, Moschos M, Theodossiadis G, Kouvatseas G.                                           

Ocul Immunol Inflamm. 2007;15(2):71-9.

49.   anti-TNF therapy in the management of Behcet disease--review and basis for recommendations.    

Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H.

Rheumatology (Oxford). 2007;46(5):736-41.

48.   Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation.                                                                                    

Theodossiadis PG, Markomichelakis NN, Sfikakis PP.                                                                           

Retina. 2007;27(4):399-413.

47.   Acanthamoeba keratitis and contact lens disifecting solutions                                     

Tzanetou K, Miltsakakis D, Droutsas D, Alimisi S, Petropoulou D, Ganteris G, Dolapsaki E, Markomichelakis N, Mallias I, Malamou-Lada E.                                                          

Ophthalmologica 2006;220:238-41

46.   Pressure wave reflections, central blood pressure, and aortic stiffness in patients with Αdamantiades-Behcet diasease: a cross-sectipnal cas- controle study underlining the role of chronic corticosteroid treatment                                                          

Protogerou AD, Lekakis J, Ikonomidis I, Stamatelopoulos K, Aznaouridis K, Karatzis EN, Papamichael C, Markomichelakis N, Kaklamanis P, Mavrikakis M                                           

American Journal of Hypertension 2006;19:660-6

45.   Intravenous pulse methylprednisolone therapy for acute treatment of serpiginous choroiditis        

Markomichelakis ΝΝ, Halkiadakis Ι,Papaeythymiou-Orchan S,Giannakopoulos N, Ekonomopoulos N, Kouris T  

Ocular Immunol and Infflammation 2006;14(1):29-33.

44.   Spinal muscular atrophy, Dandy-Walker complex, and cataracts in two siblings: a new entity?       

Panas M, Spengos K, Tsivgoulis G, Kalfakis N, Sfagos C, Vassilopoulos D, Markomichelakis N. 

J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1183-4.

43.   Regression of neovascular age-related macular degeneration following infliximab therapy.

Markomichelakis NN, Theodossiadis PG, Sfikakis PP.                                                                  

American Journal of Ophthalmology. 2005;139(3):537-40.

42.   Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab                

Sfikakis PP, Markomichelakis NN, Theodossiadis GP, Grigoropoulos V, Katsilambros N Theodossiadis PG 

Diabetes Care 2005;28: 445-7

41.   Prognostic factors in Intermediate uveitis                                                         

Markomichelakis N, Chatzistefanou K, Dafni U, Christen W, Rojas B, Sohelian M, Foster S

Middle East Journal of Ophthalmology 2004;12: 155-61

40.   Characteristics of systemic disease-associated and idiopathic pars planitis

Markomichelakis NN, Chatzistefanou K, Dafni U, Christen W, Zafirakis P,Rojas B, Foster S  

Middle East Journal of Ophthalmology 2004;12:5-12

39.   Infliximab for chronic cystoid macular edema associated with uveitis       

Markomichelakis N, Theodossiadis P, Pantelia E. Theodossiadis G, Sfikakis P.             

American Journal of Ophthalmology 2004;138:648-650 .

38.   Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography.                                        

Markomichelakis NN, Halkiadakis I, Pantelia E, Peponis V, Patelis A, Theodossiadis P, Theodossiadis G.                                                                                                      

Ophthalmology. 2004 May;111:946-53

37.   Aortic elastic properties and left ventricular diastolic function in patinents with Adanatiades-Behcet’s disease     
Ikonomidis I, Lekakis J, Stamatelopoulos K, Markomichelakis N, Kaklamanis Ph, Mavrikakis M.

Journal of the American College of Cardiology Foundation, 2004;43:1075-81 

36.   Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behcet disease in Greece                                                                   

Zouboulis CC, Vaiopoulos G, Markomichelakis N, Palimeris G, Markidou I, Thouas B, Kaklamanis P.

Clinical and Experimental Rheumatology 2003; 21 (Suppl. 30); S19-S26

35.   Arterial wall characteristics in patients with Adamantiades-Behcet disease  

Protogerou A, Lekakis J, Stamatelopoulos K, Aznaouridis K, Karatzis E, Ikonomidis I, Papamichael Ch, Markomihelakis N, Mavrikakis M, Kaklamanis PG.                                                           

Advanced Experimental Medicine and Biology. 2003;528:399-404

34.   Human mast cell subtypes in conjunctiva of patients with atopic keratoconjunctivitis, ocular cicatricial pemphigoid and Stevens-Johnson syndrome. 

Yao L, Baltatzis S,  Zafirakis P, Livir-Rallatos C, Voudouri A, Markomichelakis N, Zhao T, Foster C.S

Ocular Immunology and Inflammation 2003;11:211-22.

33.   The effect of smoking on the clinical features of Adamantiades-Behcet disease

Kaklamani VG, Tzonou A, Markomichelakis N, Papazoglou S, Kaklamanis PG.      

Advanced Experimental Medicine and Biology 2003;528:323-7.

32.   Macular hole closure after peribulbar steroid injection                                          

Halkiadakis I,Pantelia E,Giannakopoulos N,Koutsandrea C,Markomichelakis N.

American Journal of Ophthalmology. 2003;136:1165-7

31.   Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behcet disease

Sfikakis PP, Kaklamanis PH, Elezoglou A, Katsilambros N, Theodossiadis PG, Papaefthimiou S, Markomichelakis N.

Annales of Internal Medicine. 2004;140:404-6

30.   Successful long-term treatment of refractory Adamantiades-Behcet disease with infliximab: report of two patients

Katsiari G, Theodossiadis PG, Kaklamanis PG, Markomichelakis N, Sfikakis P.     

Advanced Experimental Medicine and Biology 2003;528:551-5.

29.   Could Nicotine be beneficial for Behcet disease                                                           

Kaklamani VG, Markomichelakis N, Kaklamanis Ph                                                          

Clinical Rheumatology (let) 2002;21:341-342

28.   Cytomegaloviruys can cause Anterior Uveitis with Sectoral Iris Atrophy

Markomichelakis N, Canakis Ch, Zafirakis P, Marakis Th, Mallias I, Theodossiadis G.  

Ophthalmology 2202;109:879-882   

27.   Effect of Infliximab on side-threatening panuveitis in Behcet disease                      

Sfikakis P, Thedossiadis P, Katsiari C, Kaklamanis Ph, Markomichelakis N                           

Lancet 2001;358(9278):295-6.

26.   Herpes simplex virus type 2: a cause of acute retinal necrosis syndrome   

Markomichelakis N, Zafirakis P,Karampoyia P,Drakoulis N,Apostolopoulos M.                        

Ocular Immunology and Inflammation 2001;9(2):103-9.

25.   Evaluation of the hydrogel foldable intraocular lens in patients with uveitis          

Baltatzis S, Zafirakis P, Voudouri A, Livir-Ralatos G, Livir-Ralatos C, Kanakis C, Mitsionis I, Markomichelakis NN.          

Investigative Ophthalmology & Visual Science 2001;42:S5

24.   Immunopathology of ocular rosacea                                                                               

Zafirakis P, Baltatzis S, Voudouri A, Livir-Ralatos G, Livir-Ralatos C, Markomichelakis N, Foster CS         

Investigative Ophthalmology & Visual Science 2001;42S577

23.   Standard Versus separate Phacotrabeculectomy: A randomized study                       

Voudouri A, Zafirakis P, Livir-Ralatos G, Markomichelakis N, Mitsionis I, Baltatzis S,

Investigative Ophthalmology & Visual Science 2001;42:S822

22.   High levels of Tumor Necrosis Factor –a (TNF-a) in the aqueous humor in patients suffering from Adamandiades-Behcet disease: Preliminary results                              

Chronopoulou H, Tzavara N, Ekonomopoulos N, Zafirakis P, Theodosiadis P, Tzioufas T, Markomichelakis N.                                                                                                                     

Investigative Ophthalmology & Visual Science 2001;42:S708

21.   Recurrent epididymo-orchitis in patients with Behcet disease                          

Kaklamani VG, Vaiopoulos G, Markomichelakis N, Kaklamanis Ph.                                

Journal of Urology 2000; 163:487-9    

20.   Human leukocyte antigens (HLA) and intermediate uveitis                       

Markomichelakis N, Zafirakis P, Chatzistefanou C, Kokolakis S, Theodosiadis G.               

Ocular Immunology and Inflammation 2000; 8:210 

19.   Costimulatory molecules in conjunctiva from patients with Stevens Johnson syndrome

Zafirakis P, Dorfman DM, Baltatzis S, Voudouri A, Livir-Rallatos, Markomichelakis N, Foster CS  

Investigative Ophthalmology & Visual Science 2000;41:S672 

18.   Combined cyclpsporine-A, corticosteroid and azathioprine treatment for uveitis in Adamantiades-Behcet disease. Preliminary results                                                            

Markomichelakis N, Zafirakis P, Canakis C, Tziufas A, Manousakis E,Mallias I, Theodosiaidis G.

Investigative Ophthalmology & Visual Science 2000;41:S370

17.   Clinical features of Adamandiades-Behcet disease in Greece                                   

Kaklamani V, Markomichelakis N, Vaiopoulos G, Papazoglou S, Kaklamanis P.                              

Yonsei Medical Journal 2000;41(Suppl):10  

16.   Clinical features of juvenile Adamantiades-Behcet disease in Greece                     

Vaiopoulos G, Kaklamani V, Markomichelakis N,T zonou M, Mavrikakis M, Kaklamanis P.

Clinical and Experimental Rheumatology 1999;17:256-9 

15.   Retinal vasculitis with a frosted branch angiitis-like response due to herpes simplex virus type 2

Markomichelakis N, Barampouti F, Zafirakis P, Chalkiadakis I, Kouris T,Ekonomopoulos N

Retina 1999;19:455-7   

14.   CME in a patient with AIDS and past ocular history of CMV retinitis after initiation of protease inhibitors

Zafirakis P, Markomichelakis N, Venturi M, Theodosiadis P, Theodosiadis G.   

Documenta Ophthalmologica, 1999;97:311-315  

13.   Medical treatment of macular edema in patients with uveitis                                      

Rojas B, Zafirakis P, Christen W, Markomichelakis N, Foster CS.                             

Documenta Ophthalmologica, 1999;97:399-407

12.   Immunopathology of Moorens ulcer                                                                               

Zafirakis P, Baltatzis S, Livir-Ralatos C, Voudouri A, Markomichelakis N, Foster CF.

Investigative Ophthalmology & Visual Science 1999;40:S559

11.   Human mast cell subsets in conjunctiva from patients with atopy and ocular cicatricial pemphigoid

Baltatzis S, Zafirakis P, Livir-Ralatos C, Voudouri A, Markomichelakis N, Foster CF.

Investigative Ophthalmology & Visual Science 1999;40:S558  

10.   HLA-B* 5101 in greek patients with Behcet disease                                           

Koumantaki I, Stavropoulos C,Spyropoulou M,Messini H,Papademitropoulos M,Giziaki E, Markomichelakis N, Palimeris G, Kaklamanis PH, Kaklamani E.                                                    

Human Immunology 1998;59:250-5

9.      Characteristics of uveitis presenting for the first time in the elderly                         

Chatzistefanou Κ, Markomichelakis Ν, Christen W, Soheilian M,  Foster CS.       

Ophthalmology 1998;105:347-52

8.      Retinopathy and optic neuropathy after transplantation                                  

Theodosiadis P, Vergados I, Markomichelakis N, Ladas I, Skandali A. (let)           

Ophthalmology 1997;104:170-171

7.      Retinal perivasculitis in an immunocompetent patient with systemic herpes siplex virus

Chatzoulis D, Theodosiadis P, Apostolopoulos M, Drakoulis N Markomichelakis N.    

American Journal of Ophthalmology, 1997;123:699-702 

6.      DNA techniques in the diagnosis and the monitoring of treatment for systemic HSV infection of an immunocompetent patient with retinal perivasculitis                             

Haliassos A, Markomichelakis N, Drakoulis N.                                                                             

European Journal of Clinical Pharmacology 1997; 52 (Suppl):A181, 587  

5.      Intermediate uveitis and vasculitis: new ocular manifestations in cat scratch disease

Soheilian M, Markomichelakis N, Foster CS.                                                                 

American Journal of Ophthalmology, 1996;122:582-584

4.      Medical treatment of cystoid macular edema in patients with uveitis                        

Rojas B, Christen B, Markomichelakis N, Foster CS.                                                   

Investigative Ophthalmology & Visual Science 1996;36:S340   

3.      Intermediate uveitis. What is the natural course of the disease and its relationship with other systemic diseases?                                                                                                         

Palimeris G, Markomichelakis N, Konstantinidou V, Trakaniari AN.                        

European Journal of Ophthalmology 1994;3:223-27

2.      Detection of HSV, CMV, and EBV by the polymerase chain reaction technique in   patients with inflammatory eye diseases                                                

Ergazaki M, Xinarianos G, Giannoudis A, Markomichelakis N,Tsamparlakis I,Spandidos D.

Oncology Reports 1994;1:1207-13

1.   ND:YAG LASER coreoplasty in a patient with ocular leprosy                                             

Ladas I, Markomichelakis N, Makrinori F.

In: Recent Advances in Uveitis. Dernouchamps J, Verougstraete C, Caspers-Velou L, Tassignon MJ (edts). Kugler Publication, Amstredam 1993: 623-627                                                

Developed by LogicONE